9 Meters Biopharma, Inc. (NMTR) Comparison with companies in other sectors?

9 Meters Biopharma, Inc. has a share price of 14.46M. You can analyze 9 Meters Biopharma, Inc. (NMTR) competitors across different market sectors through stock heatmaps.

What are NMTR's NET and operating margins?

9 Meters Biopharma, Inc. (NMTR) operating margin is around 0.00, and net profit margin is approximately 0.00 as of the latest reports.

In what way does NMTR's earnings per share (EPS) trend reflect its financial momentum?

9 Meters Biopharma, Inc. (NMTR) EPS is -1.69 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for 9 Meters Biopharma, Inc. is -0.04, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for 9 Meters Biopharma, Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for 9 Meters Biopharma, Inc. like P/E which is -0.02, P/B which is 0.39, and PEG which is -0.00. Compare them with sector averages to evaluate if the stock is priced fairly.

9 Meters Biopharma, Inc.

NMTR•NASDAQ

Healthcare

Biotechnology

$0.07

$-0.05(-42.97%)

Fundamental Analysis of 9 Meters Biopharma, Inc. (NMTR)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$-1.69

P/E Ratio

-0.04272189349112426

ROE

-2.07%

Net Margin

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$1.04M

Shares OutstandingTotal number of shares issued

$14.46M

Book Value/ShareNet worth per share

$0.19

Revenue/ShareAnnual revenue per share

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-1.69

Net MarginNet income as percentage of revenue

Operating MarginOperating income as percentage of revenue

ROEReturn on shareholders' equity

-206.87%

ROAReturn on total assets

-137.31%

ROCEReturn on capital employed

-1713.63%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$-2.87

Cash/ShareCash and equivalents per share

$0.98

FCF YieldFree cash flow as percentage of market cap

-3567.66%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Understanding Fundamental Analysis for Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a comprehensive method of evaluating a company's intrinsic value by examining its financial statements, management quality, competitive advantages, and market position. This analytical approach focuses on determining whether a stock is undervalued or overvalued based on its underlying business fundamentals, providing investors with essential insights for making informed investment decisions.

Key Financial Metrics and Ratios

Essential financial metrics include earnings per share (EPS), price-to-earnings (P/E) ratio, return on equity (ROE), debt-to-equity ratio, and free cash flow. These metrics provide insights into profitability, valuation, financial health, and operational efficiency. Understanding these ratios helps investors compare companies within the same industry and identify potential investment opportunities or risks.

Profitability and Efficiency Analysis

Profitability metrics such as net margin, operating margin, return on assets (ROA), and return on capital employed (ROCE) demonstrate how effectively a company generates profits from its operations. High profitability ratios often indicate strong management, competitive advantages, and sustainable business models. These metrics are crucial for evaluating long-term investment potential and comparing performance across industry peers.

Valuation and Market Position

Valuation ratios including price-to-book (P/B), price-to-sales (P/S), and price-to-earnings-growth (PEG) help determine whether a stock is fairly valued relative to its fundamentals and growth prospects. These ratios, combined with market capitalization and competitive positioning, provide insights into market expectations and potential investment returns. Proper valuation analysis is essential for identifying undervalued opportunities and avoiding overpriced securities.

Risk Assessment and Financial Health

Financial health indicators such as current ratio, debt-to-equity ratio, and cash flow metrics help assess a company's ability to meet its obligations and weather economic downturns. Strong balance sheets with manageable debt levels, adequate liquidity, and consistent cash generation provide stability and flexibility during challenging market conditions. These factors are crucial for risk management in investment portfolios.

Long-term Investment Strategy

Fundamental analysis supports long-term investment strategies by focusing on business quality, competitive moats, and sustainable growth prospects rather than short-term market fluctuations. Investors using fundamental analysis typically seek companies with strong financials, capable management, and clear competitive advantages that can generate consistent returns over extended periods. This approach emphasizes value creation and business fundamentals over market timing and speculation.

Fundamental Analysis FAQ

;